Back to library
Weight Management

5-Amino-1MQ

An oral small-molecule NNMT inhibitor. Blocks nicotinamide N-methyltransferase to boost NAD+ and promote fat loss in adipose tissue.

Half-life: ~8 hours (oral)Once daily with foodStandard · ≤10 mg/mL
Order: Coming soon

Overview

Clinical Benefits
  • Increases cellular NAD+
  • Targets visceral fat reduction
  • Improves metabolic rate
  • May enhance endurance
Administration

Oral capsule with food (not injected)

Drug class: nnmt inhibitor

Clinical Dosing

Typical dosage
50-150mg daily (oral capsule)
Starting dose
50mg
Cadence
Once daily with food
Full titration schedule
PhaseDose
Weeks 1-250mg once daily
Weeks 3-4100mg once daily
Weeks 5-12100-150mg once daily
Weeks 13+Cycle off 4 weeks

Safety Profile

Side effects
  • • Mild GI upset
  • • Dry mouth
  • • Limited human trial data
Contraindications
  • • Pregnancy
  • • Liver disease

Frequently asked questions

5-Amino-1MQ is most commonly researched for: Increases cellular NAD+, Targets visceral fat reduction, Improves metabolic rate, May enhance endurance.

Ready to build a protocol with 5-Amino-1MQ?

LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.

You’ll be asked to sign in first. Free tier includes the chat preview.

Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.

Add to Home Screen

Install PeptideAI for quick access and an app-like experience.